A Study of Reverse Causation: Examining the Associations of Perfluorooctanoic Acid Serum Levels with Two Outcomes

Overview

Journal Environ Health Perspect

Date 2016 Aug 17

PMID 27529882

Citations 39

Authors

Radhika Dhingra

Andrea Winquist

Lyndsey A Darrow

Mitchel Klein

Kyle Steenland

Affiliations

Soon will be listed here.

Abstract

Background: Impaired kidney function and earlier menopause were associated with perfluorooctanoic acid (PFOA) serum levels in previous cross-sectional studies. Reverse causation, whereby health outcomes increase serum PFOA, may underlie these associations.

Objective: We compared measured (subject to reverse causation) versus modeled (unaffected by reverse causation) serum PFOA in association with these outcomes to examine the possible role of reverse causation in these associations.

Methods: In cross-sectional analyses, we analyzed PFOA in relation to self-reported menopause among women ( = 9,192) 30-65 years old and in relation to kidney function among adults > 20 years old ( = 29,499) in a highly exposed Mid-Ohio Valley cohort. Estimated glomerular filtration rate (eGFR, a marker of kidney function) and serum PFOA concentration were measured in blood samples collected during 2005-2006. Retrospective year-specific serum PFOA estimates were modeled independently of measured PFOA based on residential history and plant emissions. Using measured and modeled PFOA in 2005 or 2006 (predictor variables), cross-sectional associations were assessed for eGFR and menopause (yes/no). We also analyzed measured PFOA (dependent variable) in relation to the number of years since menopause.

Results: Menopause and eGFR were significantly associated with measured (trend tests: = 0.013, = 0.0005, respectively) but not with modeled serum PFOA ( = 0.50, = 0.76, respectively). Measured PFOA levels increased for the first 7 years after menopause (trend test, < 0.0001), providing further evidence that the observed association between measured PFOA and menopause is subject to reverse causation for this outcome.

Conclusion: Our results support the conjecture that in previous studies, earlier menopause and reduced kidney function are the causes rather than the results of increased measured serum PFOA. These results suggest caution in using biomarkers in cross-sectional studies. Citation: Dhingra R, Winquist A, Darrow LA, Klein M, Steenland K. 2017. A study of reverse causation: examining the associations of perfluorooctanoic acid serum levels with two outcomes. Environ Health Perspect 125:416-421; http://dx.doi.org/10.1289/EHP273.

Citing Articles

Effects of Per- and Polyfluoroalkylated Substances on Female Reproduction.

Gonzalez-Alvarez M, Antwi-Boasiako C, Keating A Toxics. 2024; 12(7.

PMID: 39058107 PMC: 11280844. DOI: 10.3390/toxics12070455.

Water, Water Everywhere, but Every Drop Unique: Challenges in the Science to Understand the Role of Contaminants of Emerging Concern in the Management of Drinking Water Supplies.

Glassmeyer S, Burns E, Focazio M, Furlong E, Gribble M, Jahne M Geohealth. 2023; 7(12):e2022GH000716.

PMID: 38155731 PMC: 10753268. DOI: 10.1029/2022GH000716.

Serum concentrations of per- and polyfluoroalkyl substances and risk of renal cell carcinoma in the Multiethnic Cohort Study.

Rhee J, Chang V, Cheng I, Calafat A, Botelho J, Shearer J Environ Int. 2023; 180:108197.

PMID: 37741007 PMC: 11093414. DOI: 10.1016/j.envint.2023.108197.

Per- and Polyfluoroalkyl Substances (PFAS) and Lipid Trajectories in Women 45-56 Years of Age: The Study of Women's Health Across the Nation.

Kang H, Ding N, Karvonen-Gutierrez C, Mukherjee B, Calafat A, Park S Environ Health Perspect. 2023; 131(8):87004.

PMID: 37552133 PMC: 10408595. DOI: 10.1289/EHP12351.

Perfluorooctanoic acid (PFOA) exposure in relation to the kidneys: A review of current available literature.

Liu D, Yan S, Wang P, Chen Q, Liu Y, Cui J Front Physiol. 2023; 14:1103141.

PMID: 36776978 PMC: 9909492. DOI: 10.3389/fphys.2023.1103141.

References

Barry V, Winquist A, Steenland K . Perfluorooctanoic acid (PFOA) exposures and incident cancers among adults living near a chemical plant. Environ Health Perspect. 2013; 121(11-12):1313-8. PMC: 3855514. DOI: 10.1289/ehp.1306615. View

Frisbee S, Brooks Jr A, Maher A, Flensborg P, Arnold S, Fletcher T . The C8 health project: design, methods, and participants. Environ Health Perspect. 2010; 117(12):1873-82. PMC: 2799461. DOI: 10.1289/ehp.0800379. View

Costa G, Sartori S, Consonni D . Thirty years of medical surveillance in perfluooctanoic acid production workers. J Occup Environ Med. 2009; 51(3):364-72. DOI: 10.1097/JOM.0b013e3181965d80. View

Clark W, Sontrop J, Macnab J, Suri R, Moist L, Salvadori M . Urine volume and change in estimated GFR in a community-based cohort study. Clin J Am Soc Nephrol. 2011; 6(11):2634-41. PMC: 3359569. DOI: 10.2215/CJN.01990211. View

Calafat A, Wong L, Kuklenyik Z, Reidy J, Needham L . Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect. 2007; 115(11):1596-602. PMC: 2072821. DOI: 10.1289/ehp.10598. View

Bartell S, Calafat A, Lyu C, Kato K, Ryan P, Steenland K . Rate of decline in serum PFOA concentrations after granular activated carbon filtration at two public water systems in Ohio and West Virginia. Environ Health Perspect. 2010; 118(2):222-8. PMC: 2831921. DOI: 10.1289/ehp.0901252. View

Harada K, Koizumi A, Saito N, Inoue K, Yoshinaga T, Date C . Historical and geographical aspects of the increasing perfluorooctanoate and perfluorooctane sulfonate contamination in human serum in Japan. Chemosphere. 2006; 66(2):293-301. DOI: 10.1016/j.chemosphere.2006.05.010. View

Rodstrom K, Bengtsson C, Lissner L, Bjorkelund C . Reproducibility of self-reported menopause age at the 24-year follow-up of a population study of women in Göteborg, Sweden. Menopause. 2005; 12(3):275-80. DOI: 10.1097/01.gme.0000135247.11972.b3. View

Frisbee S, Shankar A, Knox S, Steenland K, Savitz D, Fletcher T . Perfluorooctanoic acid, perfluorooctanesulfonate, and serum lipids in children and adolescents: results from the C8 Health Project. Arch Pediatr Adolesc Med. 2010; 164(9):860-9. PMC: 3116641. DOI: 10.1001/archpediatrics.2010.163. View

10.

Lorber M, Eaglesham G, Hobson P, Toms L, Mueller J, Thompson J . The effect of ongoing blood loss on human serum concentrations of perfluorinated acids. Chemosphere. 2014; 118:170-7. DOI: 10.1016/j.chemosphere.2014.07.093. View

11.

Shankar A, Xiao J, Ducatman A . Perfluoroalkyl chemicals and chronic kidney disease in US adults. Am J Epidemiol. 2011; 174(8):893-900. PMC: 3218627. DOI: 10.1093/aje/kwr171. View

12.

Haroun M, Jaar B, Hoffman S, Comstock G, Klag M, Coresh J . Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol. 2003; 14(11):2934-41. DOI: 10.1097/01.asn.0000095249.99803.85. View

13.

Steenland K, Jin C, MacNeil J, Lally C, Ducatman A, Vieira V . Predictors of PFOA levels in a community surrounding a chemical plant. Environ Health Perspect. 2009; 117(7):1083-8. PMC: 2717134. DOI: 10.1289/ehp.0800294. View

14.

Crawford S, Johannes C, Stellato R . Assessment of digit preference in self-reported year at menopause: choice of an appropriate reference distribution. Am J Epidemiol. 2002; 156(7):676-83. DOI: 10.1093/aje/kwf059. View

15.

Hernan M, Cole S . Invited Commentary: Causal diagrams and measurement bias. Am J Epidemiol. 2009; 170(8):959-62. PMC: 2765368. DOI: 10.1093/aje/kwp293. View

16.

Watkins D, Josson J, Elston B, Bartell S, Shin H, Vieira V . Exposure to perfluoroalkyl acids and markers of kidney function among children and adolescents living near a chemical plant. Environ Health Perspect. 2013; 121(5):625-30. PMC: 3673193. DOI: 10.1289/ehp.1205838. View

17.

Knox S, Jackson T, Javins B, Frisbee S, Shankar A, Ducatman A . Implications of early menopause in women exposed to perfluorocarbons. J Clin Endocrinol Metab. 2011; 96(6):1747-53. PMC: 3206400. DOI: 10.1210/jc.2010-2401. View

18.

Dhingra R, Darrow L, Klein M, Winquist A, Steenland K . Perfluorooctanoic acid exposure and natural menopause: A longitudinal study in a community cohort. Environ Res. 2016; 146:323-30. DOI: 10.1016/j.envres.2015.12.037. View

19.

Wong F, MacLeod M, Mueller J, Cousins I . Enhanced elimination of perfluorooctane sulfonic acid by menstruating women: evidence from population-based pharmacokinetic modeling. Environ Sci Technol. 2014; 48(15):8807-14. DOI: 10.1021/es500796y. View

20.

Steenland K, Tinker S, Frisbee S, Ducatman A, Vaccarino V . Association of perfluorooctanoic acid and perfluorooctane sulfonate with serum lipids among adults living near a chemical plant. Am J Epidemiol. 2009; 170(10):1268-78. DOI: 10.1093/aje/kwp279. View